Research ExplorerResearch UnitsDepartment of Gynecology Publications

Department of Gynecology

1 - 50 out of 897Page size: 50

Publications

  1. 2024

  2. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants

    Riecke, K., Steinhilper, L., von Bülow, C., Schwarz, D., Burandt, E., Striefler, J. K., Müller, V., Schmalfeldt, B. & Witzel, I., 02.2024, In: BREAST CARE. 19, 1, p. 73-76 4 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  3. Unveiling breast cancer metastasis through an advanced X-ray imaging approach

    Conceição, A. L. C., Müller, V., Burandt, E-C., Mohme, M., Nielsen, L. C., Liebi, M. & Haas, S., 16.01.2024, In: SCI REP-UK. 14, 1, p. 1448

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis

    Weigelt, J., Petrosyan, M., Oliveira-Ferrer, L., Schmalfeldt, B., Bartmann, C., Dietl, J., Stürken, C. & Schumacher, U., 08.01.2024, In: BMC CANCER. 24, 1, p. 43

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial

    Fehm, T., Mueller, V., Banys-Paluchowski, M., Fasching, P. A., Friedl, T. W. P., Hartkopf, A., Huober, J., Loehberg, C., Rack, B., Riethdorf, S., Schneeweiss, A., Wallwiener, D., Meier-Stiegen, F., Krawczyk, N., Jaeger, B., Reinhardt, F., Hoffmann, O., Mueller, L., Wimberger, P., Ruckhaeberle, E., Blohmer, J-U., Cieslik, J-P., Franken, A., Niederacher, D., Neubauer, H., Pantel, K., Janni, W. & DETECT Study Group, 04.01.2024, In: CLIN CHEM. 70, 1, p. 307-318 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2023

  7. Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)

    Decker, T., Lüdtke-Heckenkamp, K., Melnichuk, L., Hirmas, N., Lübbe, K., Zahn, M-O., Schmidt, M., Denkert, C., Lorenz, R., Müller, V., Zahm, D-M., Mundhenke, C., Bauer, S., Thill, M., Seropian, P., Filmann, N. & Loibl, S., 12.2023, In: BREAST. 72, p. 103575

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry

    Mandelkow, T., Bady, E., Lurati, M. C. J., Raedler, J. B., Müller, J. H., Huang, Z., Vettorazzi, E., Lennartz, M., Clauditz, T. S., Lebok, P., Steinhilper, L., Woelber, L., Sauter, G., Berkes, E., Bühler, S., Paluchowski, P., Heilenkötter, U., Müller, V., Schmalfeldt, B., von der Assen, A., Jacobsen, F., Krech, T., Krech, R. H., Simon, R., Bernreuther, C., Steurer, S., Burandt, E. & Blessin, N. C., 29.11.2023, In: BIOMEDICINES. 11, 12, 3175.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer

    Volk, A., Legler, K., Hamester, F., Kuerti, S., Eylmann, K., Rossberg, M., Schmalfeldt, B. & Oliveira-Ferrer, L., 11.2023, In: J CANCER RES CLIN. 149, 17, p. 15957-15967 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

    Hermsen, M. A., Lechner, M., Oliveira Ferrer, L., Trama, A., Eriksen, P. R. G., Martinez-Balibrea, E. & von Buchwald, C., 11.2023, In: ORAL ONCOL. 146, p. 106543

    Research output: SCORING: Contribution to journal › Comment/debate › Research

  11. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Kurtz, J-E., Pujade-Lauraine, E., Oaknin, A., Belin, L., Leitner, K., Cibula, D., Denys, H., Rosengarten, O., Rodrigues, M., de Gregorio, N., Martinez García, J., Petru, E., Kocián, R., Vergote, I., Pautier, P., Schmalfeldt, B., Gaba, L., Polterauer, S., Mouret Reynier, M-A., Sehouli, J., Churruca, C., Selle, F., Joly, F., D'Hondt, V., Bultot-Boissier, É., Lebreton, C., Lotz, J-P., Largillier, R., Heudel, P-E., Heitz, F. & ATALANTE/ENGOT-ov29 Investigators, 20.10.2023, In: J CLIN ONCOL. 41, 30, p. 4768-4778 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial

    Williams, T. M., Schneeweiss, A., Jackisch, C., Shen, C., Weber, K. E., Fasching, P. A., Denkert, C., Furlanetto, J., Heinmöller, E., Schmatloch, S., Karn, T., Szeto, C. W., van Mackelenbergh, M. T., Nekljudova, V., Stickeler, E., Soon-Shiong, P., Schem, C., Mairinger, T., Müller, V., Marme, F., Untch, M. & Loibl, S., 01.09.2023, In: CLIN CANCER RES. 29, 17, p. 3384-3394 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer Therapies

    Kolberg, H-C., Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Gyn, Z., Thomssen, C., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., Wöckel, A., Harbeck, N., Stickeler, E., Bartsch, R., Schneeweiss, A., Ettl, J., Krug, D., Taran, F-A., Lüftner, D. & Würstlein, R., 09.2023, In: GEBURTSH FRAUENHEILK. 83, 9, p. 1117-1126 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  14. Major influencing factors on routine implementation of shared decision‑making in cancer care: qualitative process evaluation of a stepped‑wedge cluster randomized trial

    Hahlweg, P., Lindig, A., Frerichs, W., Zill, J. M., Hanken, H., Müller, V., Peters, M. C. & Scholl, I., 08.08.2023, In: BMC HEALTH SERV RES. 23, 1, p. 840 840.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial

    Harbeck, N., Nitz, U. A., Christgen, M., Kümmel, S., Braun, M., Schumacher, C., Potenberg, J., Tio, J., Aktas, B., Forstbauer, H., Grischke, E-M., Scheffen, I., Malter, W., von Schumann, R., Just, M., Zu Eulenburg, C., Biehl, C., Kolberg-Liedtke, C., Deurloo, R., de Haas, S., Jóźwiak, K., Hauptmann, M., Kates, R., Graeser, M., Wuerstlein, R., Kreipe, H. H., Gluz, O. & WSG-ADAPT investigators, 01.08.2023, In: J CLIN ONCOL. 41, 22, p. 3796-3804 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany

    van der Ven, J., Linz, V. C., Anic, K., Schmidt, M. W., Loewe, A., Krajnak, S., Schmidt, M., Kommoss, S., Schmalfeldt, B., Sehouli, J., Hasenburg, A. & Battista, M. J., 08.2023, In: ARCH GYNECOL OBSTET. 308, 2, p. 527-534 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

    Park-Simon, T-W., Müller, V., Jackisch, C., Albert, U-S., Banys-Paluchowski, M., Bauerfeind, I., Blohmer, J-U., Budach, W., Dall, P., Ditsch, N., Fallenberg, E. M., Fasching, P. A., Fehm, T., Friedrich, M., Gerber, B., Gluz, O., Harbeck, N., Hartkopf, A. D., Heil, J., Huober, J., Kolberg-Liedtke, C., Kreipe, H. H., Krug, D., Kühn, T., Kümmel, S., Loibl, S., Lüftner, D., Lux, M. P., Maass, N., Mundhenke, C., Reimer, T., Rhiem, K., Rody, A., Schmidt, M., Schneeweiss, A., Schütz, F., Sinn, H. P., Solbach, C., Solomayer, E-F., Stickeler, E., Thomssen, C., Untch, M., Witzel, I., Wöckel, A., Wuerstlein, R., Janni, W. & Thill, M., 08.2023, In: BREAST CARE. 18, 4, p. 288-304 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  18. Impact of Introducing a PACU24 Concept on the Perioperative Outcome of Patients with Advanced Ovarian Cancer Treated with Cytoreductive Surgery

    Reuter, S., Schmalfeldt, B., Haas, S. A., Zapf, A., Cevirme, S., Prieske, K., Wölber, L., Müller, V., Zöllner, C. & Jaeger, A., 08.2023, In: GEBURTSH FRAUENHEILK. 83, 8, p. 1022-1030 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)

    Chekerov, R., Arndt, T., Pietzner, K., Canzler, U., Wimberger, P., Strauß, H-G., Mahner, S., Woelber, L., de Gregorio, N., Stocker, G., von Abel, E., Neunhoeffer, T., Belau, A. K., Mustea, A., Yalinkaya, I., Braicu, E. I., Richter, R., Sehouli, J. & NOGGO ovarian cancer study group, 08.2023, In: J CANCER RES CLIN. 149, 10, p. 7637-7649 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

    Kempska, J., Oliveira-Ferrer, L., Grottke, A., Qi, M., Alawi, M., Meyer, F., Borgmann, K., Hamester, F., Eylmann, K., Rossberg, M., Smit, D. J., Jücker, M., Laakmann, E., Witzel, I., Schmalfeldt, B., Müller, V. & Legler, K., 06.07.2023, In: FRONT ONCOL. 13, p. 1129682 1129682.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial

    Fasching, P. A., Szeto, C., Denkert, C., Benz, S., Weber, K., Spilman, P., Budczies, J., Schneeweiss, A., Stickeler, E., Schmatloch, S., Jackisch, C., Karn, T., Sinn, H. P., Warm, M., van Mackelenbergh, M., Rabizadeh, S., Schem, C., Heinmöller, E., Mueller, V., Marmé, F., Soon-Shiong, P., Nekljudova, V., Untch, M. & Loibl, S., 05.07.2023, In: CLIN CANCER RES. 29, 13, p. 2456-2465 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

    Oonk, M. H. M., Planchamp, F., Baldwin, P., Mahner, S., Mirza, M. R., Fischerová, D., Creutzberg, C. L., Guillot, E., Garganese, G., Lax, S., Redondo, A., Sturdza, A., Taylor, A., Ulrikh, E., Vandecaveye, V., van der Zee, A., Wölber, L., Zach, D., Zannoni, G. F. & Zapardiel, I., 03.07.2023, In: INT J GYNECOL CANCER. 33, 7, p. 1023-1043 21 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group

    Wimberger, P., Pfisterer, J., du Bois, A., Hilpert, F., Kerkmann, M., Sehouli, J., Mahner, S., de Gregorio, N., Hanker, L., Heitz, F., Marmé, F., Woelber, L., Holtmann, L., Elser, G., Harter, P. & AGO Study Group, 03.07.2023, In: INT J GYNECOL CANCER. 33, 7, p. 1083-1089 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial

    Gluz, O., Nitz, U. A., Christgen, M., Kuemmel, S., Holtschmidt, J., Schumacher, J., Hartkopf, A., Potenberg, J., Lüedtke-Heckenkamp, K., Just, M., Schem, C., von Schumann, R., Kolberg-Liedtke, C., Eulenburg, C. Z., Schinköthe, T., Graeser, M., Wuerstlein, R., Kates, R. E., Kreipe, H. H. & Harbeck, N., 01.07.2023, In: JAMA ONCOL. 9, 7, p. 946-954 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 'Case of the Month' from University Medical Center Hamburg-Eppendorf, Germany: Vulvar cancer after female-male gender reassignment

    Finger, A. E., Riechardt, S., Dahlem, R., Soave, A., Rink, M., Sauter, G., Contreras, H., Steinhilper, L., Fisch, M., Vetterlein, M. W. & Schuettfort, V. M., 06.2023, In: BJU INT. 131, 6, p. 685-688 4 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  26. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry

    Riecke, K., Müller, V., Neunhöffer, T., Park-Simon, T-W., Weide, R., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Wuerstlein, R., Denkert, C., Decker, T., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Laakmann, E. & Witzel, I., 06.2023, In: ESMO OPEN. 8, 3, p. 101213

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2- early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2- trial

    Gluz, O., Kuemmel, S., Nitz, U., Braun, M., Lüdtke-Heckenkamp, K., von Schumann, R., Darsow, M., Forstbauer, H., Potenberg, J., Uleer, C., Grischke, E. M., Aktas, B., Schumacher, C., Zu Eulenburg, C., Kates, R., Jóźwiak, K., Graeser, M., Wuerstlein, R., Baehner, R., Christgen, M., Kreipe, H. H. & Harbeck, N., 06.2023, In: ANN ONCOL. 34, 6, p. 531-542 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare

    Müller, V., Fasching, P. A., Nabieva, N., Fehm, T. N., Thill, M., Schmidt, M., Kühn, T., Banys-Paluchowski, M., Belleville, E., Juhasz-Böss, I., Untch, M., Kolberg, H-C., Harbeck, N., Aktas, B., Stickeler, E., Kreuzeder, J., Hartkopf, A. D., Janni, W. & Ditsch, N., 06.2023, In: GEBURTSH FRAUENHEILK. 83, 6, p. 673-685 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  29. Update Breast Cancer 2023 Part 1 - Early Stage Breast Cancer

    Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Witzel, I., Thomssen, C., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., Wöckel, A., Kolberg, H-C., Harbeck, N., Stickeler, E., Bartsch, R., Schneeweiss, A., Ettl, J., Würstlein, R., Krug, D., Taran, F-A. & Lüftner, D., 06.2023, In: GEBURTSH FRAUENHEILK. 83, 6, p. 653-663 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer

    Lux, M. P., Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Witzel, I., Thomssen, C., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., Wöckel, A., Kolberg, H-C., Harbeck, N., Bartsch, R., Schneeweiss, A., Ettl, J., Würstlein, R., Krug, D., Taran, F-A., Lüftner, D. & Stickeler, E., 06.2023, In: GEBURTSH FRAUENHEILK. 83, 6, p. 664-672 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant

    Degenhardt, T., Fasching, P. A., Lüftner, D., Müller, V., Thomssen, C., Schem, C., Witzel, I., Decker, T., Tesch, H., Kümmel, S., Uleer, C., Wuerstlein, R., Hoffmann, O., Warm, M., Marschner, N., Schinköthe, T., Kates, R. E., Schumacher, J., Otremba, B., Zaiss, M., Harbeck, N., Schmidt, M. & PreCycle Investigators, 17.05.2023, In: TRIALS. 24, 1, p. 338

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value

    Franken, A., Kraemer, A., Sicking, A., Watolla, M., Rivandi, M., Yang, L., Warfsmann, J., Polzer, B. M., Friedl, T. W. P., Meier-Stiegen, F., Stoecklein, N. H., Dayan, D., Riethdorf, S., Mueller, V., Pantel, K., Koch, A., Hartkopf, A. D., Krawczyk, N., Ruckhaeberle, E., Niederacher, D., Fehm, T. & Neubauer, H., 05.2023, In: BRIT J CANCER. 128, 9, p. 1742-1752 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis

    Meškytė, E. M., Pezzè, L., Bartolomei, L., Forcato, M., Bocci, I. A., Bertalot, G., Barbareschi, M., Oliveira-Ferrer, L., Bisio, A., Bicciato, S., Baltriukienė, D. & Ciribilli, Y., 12.04.2023, In: CELL DEATH DIS. 14, 4, p. 263

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Detection and Isolation of Circulating Tumor Cells from Breast Cancer Patients Using CUB Domain-Containing Protein 1

    Bartkowiak, K., Mossahebi Mohammadi, P., Gärtner, S., Kwiatkowski, M., Andreas, A., Geffken, M., Peine, S., Verpoort, K., Scholz, U., Deutsch, T. M., Michel, L. L., Schneeweiss, A., Thewes, V., Trumpp, A., Müller, V., Riethdorf, S., Schlüter, H. & Pantel, K., 07.04.2023, In: J PROTEOME RES. 22, 4, p. 1213-1230 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia

    Kesic, V., Carcopino, X., Preti, M., Vieira-Baptista, P., Bevilacqua, F., Bornstein, J., Chargari, C., Cruickshank, M., Erzeneoglu, E., Gallio, N., Gultekin, M., Heller, D., Joura, E., Kyrgiou, M., Madić, T., Planchamp, F., Regauer, S., Reich, O., Esat Temiz, B., Woelber, L., Zodzika, J. & Stockdale, C., 03.04.2023, In: INT J GYNECOL CANCER. 33, 4, p. 446-461 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  36. Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review

    Müller, V., Bartsch, R., Lin, N. U., Montemurro, F., Pegram, M. D. & Tolaney, S. M., 04.2023, In: CANCER TREAT REV. 115, p. 102527

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  37. Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer-An Analysis of the NOGGO/JAGO

    Heublein, S., Baum, J., Jaeger, A., Grimm-Glang, D., Olthoff, J., Braicu, E. I., Azzam Nieto, O., Hassdenteufel, K., Schmalfeldt, B., Hanker, L., Wallwiener, M., Schneeweiss, A., Sehouli, J. & Pietzner, K., 29.03.2023, In: CANCERS. 15, 7, 2038.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo

    Genduso, S., Freytag, V., Schetler, D., Kirchner, L., Schiecke, A., Maar, H., Wicklein, D., Gebauer, F., Bröker, K., Stürken, C., Milde-Langosch, K., Oliveira-Ferrer, L., Ricklefs, F. L., Ewald, F., Wolters-Eisfeld, G., Riecken, K., Unrau, L., Krause, L., Bohnenberger, H., Offermann, A., Perner, S., Sebens, S., Lamszus, K., Diehl, L., Linder, S., Jücker, M., Schumacher, U. & Lange, T., 17.03.2023, In: J HEMATOL ONCOL. 16, 1, 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

    Reimer, F., Bryan, S., Legler, K., Karn, T., Eppenberger-Castori, S., Matschke, J., Pereira-Veiga, T., Wikman, H., Witzel, I., Müller, V., Schmalfeldt, B., Milde-Langosch, K., Schumacher, U., Stürken, C. & Oliveira-Ferrer, L., 16.03.2023, In: CANCER CELL INT. 23, 1, p. 47

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

    Fehm, T. N., Welslau, M., Müller, V., Lüftner, D., Schütz, F., Fasching, P. A., Janni, W., Thomssen, C., Witzel, I., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., Hartkopf, A. D., Wöckel, A., Kolberg, H-C., Harbeck, N. & Stickeler, E., 03.2023, In: GEBURTSH FRAUENHEILK. 83, 3, p. 289-298 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Update Breast Cancer 2022 Part 6 - Advanced-Stage Breast Cancer

    Lüftner, D., Lux, M. P., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Janni, W., Thomssen, C., Witzel, I., Beierlein, M., Belleville, E., Untch, M., Thill, M., Ditsch, N., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., Wöckel, A., Kolberg, H-C., Harbeck, N., Stickeler, E., Tesch, H. & Hartkopf, A. D., 03.2023, In: GEBURTSH FRAUENHEILK. 83, 3, p. 299-309 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  42. Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT-HER2+/HR- trial

    Graeser, M., Gluz, O., Biehl, C., Ulbrich-Gebauer, D., Christgen, M., Palatty, J., Kuemmel, S., Grischke, E-M., Augustin, D., Braun, M., Potenberg, J., Wuerstlein, R., Krauss, K., Schumacher, C., Forstbauer, H., Reimer, T., Stefek, A., Fischer, H. H., Pelz, E., Zu Eulenburg, C., Kates, R., Ni, H., Kolberg-Liedtke, C., Feuerhake, F., Kreipe, H. H., Nitz, U., Harbeck, N. & WSG-ADAPT investigators, 16.02.2023, In: CLIN CANCER RES. 29, 4, p. 805-814 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging

    Gonçalves, J. P. L., Bollwein, C., Noske, A., Jacob, A., Jank, P., Loibl, S., Nekljudova, V., Fasching, P. A., Karn, T., Marmé, F., Müller, V., Schem, C., Sinn, B. V., Stickeler, E., van Mackelenbergh, M., Schmitt, W. D., Denkert, C., Weichert, W. & Schwamborn, K., 02.02.2023, In: INT J MOL SCI. 24, 3, p. 2860

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer

    Weidemann, S., Gorbokon, N., Lennartz, M., Hube-Magg, C., Fraune, C., Bernreuther, C., Clauditz, T. S., Jacobsen, F., Jansen, K., Schmalfeldt, B., Wölber, L., Paluchowski, P., Berkes, E., Heilenkötter, U., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Simon, R., Krech, T., Marx, A., Burandt, E. & Lebok, P., 01.02.2023, In: APPL IMMUNOHISTO M M. 31, 2, p. 77-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

    Pfisterer, J., Joly, F., Kristensen, G., Rau, J., Mahner, S., Pautier, P., El-Balat, A., Kurtz, J-E., Canzler, U., Sehouli, J., Heubner, M. L., Hartkopf, A. D., Baumann, K., Hasenburg, A., Hanker, L. C., Belau, A., Schmalfeldt, B., Denschlag, D., Park-Simon, T-W., Selle, F., Jackisch, C., Burges, A., Lück, H-J., Emons, G., Meier, W., Gropp-Meier, M., Schröder, W., de Gregorio, N., Hilpert, F. & Harter, P., 01.02.2023, In: J CLIN ONCOL. 41, 4, p. 893-902 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

    Lin, N. U., Murthy, R. K., Abramson, V., Anders, C., Bachelot, T., Bedard, P. L., Borges, V., Cameron, D., Carey, L. A., Chien, A. J., Curigliano, G., DiGiovanna, M. P., Gelmon, K., Hortobagyi, G., Hurvitz, S. A., Krop, I., Loi, S., Loibl, S., Mueller, V., Oliveira, M., Paplomata, E., Pegram, M., Slamon, D., Zelnak, A., Ramos, J., Feng, W. & Winer, E., 01.02.2023, In: JAMA ONCOL. 9, 2, p. 197-205 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

    Yamamoto, Y., Yamashiro, H., Schneeweiss, A., Müller, V., Gluz, O., Klare, P., Aktas, B., Magdolna, D., Büdi, L., Pikó, B., Mangel, L., Toi, M., Morita, S. & Ohno, S., 01.2023, In: BREAST CANCER-TOKYO. 30, 1, p. 88-100 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial

    Pujade-Lauraine, E., Brown, J., Barnicle, A., Wessen, J., Lao-Sirieix, P., Criscione, S. W., du Bois, A., Lorusso, D., Romero, I., Petru, E., Yoshida, H., Vergote, I., Colombo, N., Hietanen, S., Provansal, M., Schmalfeldt, B., Pignata, S., Martín Lorente, C., Berton, D., Runnebaum, I. B. & Ray-Coquard, I., 01.2023, In: JCO PRECIS ONCOL. 7, 7, p. e2200258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Return of individual genomic research results within the PRAEGNANT multicenter registry study

    Huebner, H., Ruebner, M., Kurbacher, C., Hadji, P., Hartkopf, A. D., Lux, M. P., Huober, J., Uhrig, S., Taran, F-A., Overkamp, F., Tesch, H., Häberle, L., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Hein, A., Belleville, E., Untch, M., Janni, W., Fehm, T. N., Kolberg, H-C., Wallwiener, D., Brucker, S. Y., Schneeweiss, A., Ettl, J., Fasching, P. A. & Michel, L. L., 01.2023, In: BREAST CANCER RES TR. 197, 2, p. 355-368 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Evaluation of a short instrument for measuring health-related quality of life in oncological patients in routine care (HELP-6): an observational study

    Schrage, T., Görlach, M. G., Betz, C. S., Bokemeyer, C., Kroger, N., Muller, V., Krüll, A., Schulz, H. & Bleich, C., 2023, In: FRONT PSYCHOL. 14, p. 1158449

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

    Brauneck, F., Schmalfeldt, B., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Schulze Zur Wiesch, J., Ding, Y., Qi, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2023, In: FRONT IMMUNOL. 14, p. 1250258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Impact of introducing a PACU24 concept on the perioperative outcome of patients with advanced ovarian cancer treated with cytoreductive surgery

    Reuter, S., Zapf, A., Cevirme, S., Wölber, L., Muller, V., Haas, S. A., Zöllner, C., Schmalfeldt, B. & Jaeger, A. M., 2023, In: INT J GYNECOL CANCER. 33, Suppl 3, 1011.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next